Skip to content
GLP-1 Decoder

Delaware Medicaid GLP-1 Coverage: Wegovy, Zepbound

Yes. Delaware Medicaid covers GLP-1s for weight loss. Delaware Medicaid lists Foundayo, Wegovy and Zepbound as preferred obesity drugs; every drug in the class needs prior authorization.

For weight loss
Covered with prior authorization
For type 2 diabetes
Covered
Prior authorization: Required, as noted by
Weight loss, KFF survey January 2026
Covered

Does Delaware Medicaid cover GLP-1s?

Sources: medicaidpublications.dhss.delaware.gov, KFF.

A medicine-by-medicine look at Wegovy, Zepbound, Ozempic, Mounjaro

GLP-1 drugs in Delaware Medicaid
MedicineMain useIn Delaware MedicaidEvery state
WegovyWeight lossPreferred; covered with prior authorizationWegovy and Medicaid
ZepboundWeight lossPreferred; covered with prior authorizationZepbound and Medicaid
FoundayoWeight lossPreferred; covered with prior authorizationNot listed
SaxendaWeight lossThe drug is covered with prior authorization, but the preferred list excludes itSaxenda and Medicaid
OzempicType 2 diabetesCovered for type 2 diabetes, preferredOzempic and Medicaid
MounjaroType 2 diabetesCovered for type 2 diabetes, preferredMounjaro and Medicaid
RybelsusType 2 diabetesThis drug is covered for type 2 diabetes, but it is not on the preferred listRybelsus and Medicaid
TrulicityType 2 diabetesCovered for type 2 diabetes, preferredTrulicity and Medicaid
VictozaType 2 diabetesThis drug is covered for type 2 diabetes, but it is not on the preferred listVictoza and Medicaid

You can find the preferred drug list at medicaidpublications.dhss.delaware.gov.

Rules for getting prior authorization

Source: medicaidpublications.dhss.delaware.gov.

How to check your plan

  1. Look for the drug on the state's list: Delaware Medicaid drug list.
  2. Call the member number listed on your card to ask if prior authorization is required for the drug. This applies when a managed care plan runs your Medicaid.
  3. Ask your prescriber about the preferred GLP-1, because preferred drugs are approved faster.
  4. Save the notice showing whether you were approved or denied. It identifies which rule applies to you.

Which brand pages apply to Delaware?

If Delaware Medicaid says no

If coverage says no
MedicineLowest self-payManufacturer offer if your plan does not cover the drug
Wegovy$149 a monthNot listed
Zepbound$299 a month$299 a month
Foundayo$149 a monthNot listed

Sources: foundayo.lilly.com, TrumpRx, NovoCare, CMS.